irinotecan has been researched along with isofagomine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burnouf, PA; Chen, BM; Chen, CY; Dashnyam, P; Gao, S; Hsieh, TJ; Hsieh, WC; Kuo, YH; Lin, CH; Lin, HY; Lin, TC; Roffler, SR; Tu, Z; Yeh, LF | 1 |
1 other study(ies) available for irinotecan and isofagomine
| Article | Year |
|---|---|
Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity.
Topics: Animals; Bacteria; Cell Line; Colon; Diarrhea; Disease Models, Animal; Enzyme Inhibitors; Female; Gastrointestinal Microbiome; Glucuronidase; Humans; Imino Pyranoses; Irinotecan; Mice, Inbred BALB C; Uronic Acids | 2021 |